VOYA Investment Management
KYNB

VOYA Investment Management’s Kyntra Bio KYNB Stock Holding History

VOYA Investment Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,715
Closed -$218K – 2858
2024
Q1 		$218K Sell
3,715
-4,431
-54% -$191K ﹤0.01% 2411
2023
Q4 		$181K Buy
8,146
+7,597
+1,384% +$115K ﹤0.01% 2606
2023
Q3 		$11.8K Sell
549
-893
-62% -$35.1K ﹤0.01% 2895
2023
Q2 		$97.3K Buy
1,442
+101
+8% +$41.8K ﹤0.01% 2795
2023
Q1 		$626K Sell
1,341
-11
-0.8% -$5.82K ﹤0.01% 1915
2022
Q4 		$541K Hold
1,352
– – ﹤0.01% 1995
2022
Q3 		$440K Hold
1,352
– – ﹤0.01% 2104
2022
Q2 		$357K Hold
1,352
– – ﹤0.01% 2054
2022
Q1 		$406K Sell
1,352
-6
-0.4% -$2.09K ﹤0.01% 2020
2021
Q4 		$478K Sell
1,358
-35
-3% -$10.9K ﹤0.01% 2052
2021
Q3 		$356K Buy
1,393
+3
+0.2% +$1.06K ﹤0.01% 2243
2021
Q2 		$926K Sell
1,390
-97
-7% -$55.9K ﹤0.01% 1690
2021
Q1 		$1.29M Sell
1,487
-11,869
-89% -$12.6M ﹤0.01% 1425
2020
Q4 		$12.4M Buy
13,356
+1,403
+12% +$1.47M 0.03% 492
2020
Q3 		$12.3M Sell
11,953
-615
-5% -$662K 0.03% 463
2020
Q2 		$12.7M Sell
12,568
-1,955
-13% -$1.82M 0.03% 441
2020
Q1 		$12.6M Sell
14,523
-862
-6% -$857K 0.03% 411
2019
Q4 		$16.5M Sell
15,385
-7,621
-33% -$7.78M 0.03% 438
2019
Q3 		$21.3M Buy
23,006
+1,166
+5% +$1.28M 0.05% 358
2019
Q2 		$24.7M Buy
21,840
+2,615
+14% +$2.86M 0.05% 337
2019
Q1 		$26.1M Sell
19,225
-4,039
-17% -$5.48M 0.06% 298
2018
Q4 		$26.9M Sell
23,264
-1,258
-5% -$1.41M 0.07% 282
2018
Q3 		$37.2M Sell
24,522
-4,224
-15% -$6.51M 0.08% 258
2018
Q2 		$45M Buy
28,746
+793
+3% +$1.03M 0.1% 230
2018
Q1 		$32.3M Buy
27,953
+1,129
+4% +$1.49M 0.07% 289
2017
Q4 		$31.8M Buy
26,824
+2,750
+11% +$3.45M 0.07% 299
2017
Q3 		$32.4M Buy
24,074
+22,992
+2,125% +$24.2M 0.07% 297
2017
Q2 		$873K Buy
1,082
+254
+31% +$177K ﹤0.01% 1484
2017
Q1 		$510K Hold
828
– – ﹤0.01% 1708
2016
Q4 		$443K Hold
828
– – ﹤0.01% 1820
2016
Q3 		$428K Hold
828
– – ﹤0.01% 1813
2016
Q2 		$340K Hold
828
– – ﹤0.01% 1949
2016
Q1 		$441K Hold
828
– – ﹤0.01% 1765
2015
Q4 		$630K Hold
828
– – ﹤0.01% 1561
2015
Q3 		$454K Sell
828
-95
-10% -$57.6K ﹤0.01% 1774
2015
Q2 		$543K Buy
+923
New +$537K ﹤0.01% 1861

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

VOYA Investment Management's KYNB Position: Q2 2024 in Review

VOYA Investment Management sold out of Kyntra Bio (KYNB) in Q2 2024, closing a stake of 3,715 shares — an estimated $218K sold.

VOYA Investment Management first reported a position in KYNB in Q2 2015 and held it in 36 quarters. The position peaked at $45M in Q2 2018. 102 funds tracked by Wall St. Rank hold KYNB as of Q2 2024.

  • VOYA Investment Management reported no remaining Kyntra Bio position as of Q2 2024 after selling out during the quarter.
  • VOYA Investment Management sold 3,715 Kyntra Bio shares in Q2 2024, an estimated $218K.
  • VOYA Investment Management first reported a position in Kyntra Bio in Q2 2015 and held it in 36 quarters.
  • VOYA Investment Management's Kyntra Bio position peaked at $45M in Q2 2018.
  • 102 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2024.

Based on VOYA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.